Prestige Consumer Healthcare Inc. ( PBH) - Stock Earnings
PBH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 42.2 million USD | 274.1 million USD |
| 2025Q4 | 46.7 million USD | 283.4 million USD |
| 2026Q1 | 53.9 million USD | 281.6 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PBH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 209.3 million USD | 1.1 billion USD |
| 2025 | 214.6 million USD | 1.1 billion USD |
| 2026 | 190.3 million USD | 1.1 billion USD |
| 2026 Est. | — | — |
PBH
Price: $47.10
52 week price:
Payout Ratio Range:
Earnings Per Share: 3.91 USD
P/E Ratio: 11.88
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 211300
Ebitda: 92.0 millionMarket Capitalization: 2.2 billion